Search clinical trials for: second- or third-line glucose-lowering diabetes treatment
Total 20 results
-
Royal Devon and Exeter NHS Foundation TrustKing's College London; King's College Hospital NHS Trust; Newcastle University; Newcastle-upon-Tyne Hospitals NHS Trust and other collaboratorsCompleted
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruiting
-
Chinese University of Hong KongRecruitingSubstance Abuse | Voiding DysfunctionHong Kong
-
Fudan UniversityHenan Cancer HospitalCompletedMetastatic Colorectal Cancer | Chemotherapy EffectChina
-
Sun JingNot yet recruitingColorectal Neoplasms | Colorectal Cancer
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedMalignant Solid Neoplasm | Breast Carcinoma | Ovarian Carcinoma | Colon Carcinoma | Pancreatic Carcinoma | Prostate CarcinomaUnited States
-
Thomas Jefferson UniversityRecruiting
-
The HIV Netherlands Australia Thailand Research...Ministry of Education, ThailandCompletedHIV Infections | HIV InfectionThailand
-
Göteborg UniversityCompletedDiabetic GastroparesisSweden
-
Case Comprehensive Cancer CenterTerminatedAny Cancer DiagnosisUnited States
-
RANDNational Institute of Mental Health (NIMH); Danang Psychiatric HospitalCompleted
-
Shanghai Mental Health CenterFirst Affiliated Hospital Xi'an Jiaotong University; Chinese Academy of Sciences and other collaboratorsUnknown
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedHIV InfectionsUnited States, Puerto Rico, Thailand, Botswana, Argentina, Brazil, Tanzania, South Africa
-
National Cancer Institute (NCI)Active, not recruitingB Acute Lymphoblastic Leukemia | Acute Leukemia of Ambiguous Lineage | Mixed Phenotype Acute LeukemiaUnited States, Canada, Puerto Rico, Australia
-
National Cancer Institute (NCI)SuspendedDown Syndrome | Recurrent B Acute Lymphoblastic LeukemiaUnited States, Canada, Puerto Rico, Australia
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingRecurrent Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Refractory Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Lymphoma | Clonal Cytopenia of Undetermined Significance | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsUnited States
-
National Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1United States, Canada, Australia, New Zealand, Puerto Rico
-
National Cancer Institute (NCI)Active, not recruitingB Acute Lymphoblastic Leukemia | Central Nervous System Leukemia | Testicular Leukemia | B Acute Lymphoblastic Leukemia, BCR-ABL1-LikeUnited States, Canada, Puerto Rico, Australia, New Zealand, Switzerland, Ireland
-
Children's Oncology GroupNational Cancer Institute (NCI); EsPhALL Network/ BFM Study GroupRecruitingAcute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | T Acute Lymphoblastic Leukemia | Mixed Phenotype Acute LeukemiaUnited States, Canada, Puerto Rico, Australia, Finland, New Zealand, Saudi Arabia, Germany, Austria, Belgium, Chile, Czechia, France, Italy, Netherlands, Sweden, Switzerland, Hong Kong, Israel